US President Donald Trump announced on May 12 his intention to reduce drug prices in the United States.

Trump stated that he plans to align drug prices in the US with those in other countries, particularly in Europe.

He criticized the European Union for allegedly pressuring pharmaceutical companies to lower prices within its borders.

The President referred to the EU’s actions as ‘brutal’ and claimed that they were unfairly impacting drug prices in the US.

Trump’s announcement comes amid ongoing efforts to address rising healthcare costs in the country.

The move is seen as a significant step towards fulfilling one of Trump’s key campaign promises.

Critics argue that implementing such a policy could have far-reaching implications for the pharmaceutical industry.

The issue of drug pricing has been a contentious topic in US politics, with both Democrats and Republicans proposing various solutions.

It remains to be seen how Trump’s plan will be implemented and its potential impact on the healthcare system.